| Literature DB >> 30453603 |
Ibukun Ogunade1, Hank Schweickart2, Kenneth Andries3, Jerusha Lay4, James Adeyemi5.
Abstract
To identify differences in rumen function as a result of feeding monensin to beef cattle, rumen fluid metagenomics and metabolomics analyses were used to evaluate the functional attributes and metabolites of rumen microbiota in beef steers fed no or 200 mg/d of monensin. Eight rumen-fistulated steers were used in the study for a period of 53 days. Rumen fluid samples were collected on the last day of the experiment. Monensin increased the relative abundance of Selenomonas sp. ND2010, Prevotella dentalis, Hallella seregens, Parabacteroides distasonis, Propionispira raffinosivorans, and Prevotella brevis, but reduced the relative abundance of Robinsoniella sp. KNHs210, Butyrivibrio proteoclasticus, Clostridium botulinum, Clostridium symbiosum, Burkholderia sp. LMG29324, and Clostridium butyricum. Monensin increased the relative abundance of functional genes involved in amino acid metabolism and lipid metabolism. A total of 245 metabolites were identified. Thirty-one metabolites were found to be differentially expressed. Pathway analysis of the differentially expressed metabolites revealed upregulated metabolic pathways associated with metabolism of linoleic acid and some amino acids. These findings confirm that monensin affects rumen fermentation of forage-fed beef cattle by modulating the rumen microbiome, and by reducing amino acid degradation and biohydrogenation of linoleic acid in the rumen.Entities:
Keywords: beef cattle; metabolomics; metagenomics; monensin; rumen fluid
Year: 2018 PMID: 30453603 PMCID: PMC6262558 DOI: 10.3390/ani8110211
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Linear discriminant analysis effect size (LEfSe) of rumen microbiota of beef steer fed no (control) or 200 mg/d of monensin. The linear discriminant analysis plot indicates the most differentially abundant taxa found by ranking according to their effect size (≥2.0) at the genus (A) and species level (B). The taxa enriched in steers fed the control diet are indicated with a positive score (green), and taxa enriched by the monensin treatment have a negative score (red). Only taxa meeting the significant threshold of 2.0 are shown.
Figure 2(A) Distribution of category of the predicted genes by KEGG. (B) Differential KEGG gene functions. Differences between control and monensin samples were tested for significance using a Mann Whitney test (p ≤ 0.05).
Figure 3Relative abundance of the category of carbohydrate-active enzymes according to carbohydrate-active enzyme (CAZy) database. AA = Auxilliary Activities, CBM = Carbohydrate Binding Modules, CE = Carbohydrate Esterases, GH = Glycoside Hydrolases, GT = Glycosyl Transferases, PL = Polysaccharide Lyases.
Figure 4(A) The scores plot of PCA model showing the directions that best explain the variance between the two treatments. (B) OPLS-DA score plot of all metabolite features. Group 1 = steers fed Control diet, Group 2 = steers fed 200 mg d−1 of monensin. One data point represents one composite rumen fluid sample of each steer.
Fold changes of differential rumen fluid metabolites in beef steers fed no or 200 mg d−1 of monensin.
| Metabolite | FC | |
|---|---|---|
| Acetate (mM) | 0.87 | 0.05 |
| 4-aminophenol | 0.80 | 0.09 |
| Trans-cinnamaldehyde | 1.31 | 0.07 |
| Hypoxanthine | 1.20 | 0.08 |
| Tyramine | 0.90 | 0.07 |
| Formylindole | 1.37 | 0.09 |
| Indole-3-carboxylic acid | 1.44 | 0.05 |
| 1.75 | 0.03 | |
| 3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)pyridine | 0.81 | 0.05 |
| 4-pyridoxic acid | 0.80 | 0.07 |
| Simazine | 1.23 | 0.03 |
| 1,3-dipropyl-7-methylxanthine | 0.65 | 0.02 |
| 2-(1,3-benzodioxol-5-yl)ethyl-4-methoxy-2H-pyranone | 1.45 | 0.09 |
| Pentalenolactone | 0.65 | 0.02 |
| 1.76 | 0.04 | |
| Vildagliptin | 0.70 | 0.06 |
| Oxybuprocaine | 1.41 | 0.05 |
| Tri- | 1.48 | 0.01 |
| Isopongaflavone | 1.56 | 0.07 |
| Daphnoretine acetate | 1.48 | 0.02 |
| 1.96 | 0.01 | |
| Oxysporidinone | 1.24 | 0.02 |
| Catechol | 1.42 | 0.03 |
| 2-methylgluric acid | 1.13 | 0.08 |
| Oxypurinol | 1.23 | 0.02 |
| protocatechuic acid | 1.39 | 0.01 |
| Pimelic acid | 1.38 | 0.01 |
| Isobutylglutaric acid | 1.13 | 0.05 |
| Apigenin | 0.80 | 0.06 |
| Linoleic acid | 1.61 | 0.03 |
| Eriodictyol 7,3′-dimethyl ether | 1.17 | 0.09 |
| 8,15-DiHETE | 1.48 | 0.02 |
FC = fold change, mean value of peak intensity obtained from monensin group ÷ mean value of peak intensity obtained from control group. FC values >1 means that metabolite is greater in steers fed monensin and FC values < 1 means that metabolite is lower in steers fed monensin.
Metabolic pathway analysis of the differential metabolites.
| Annotation | Impact | TC | Hit | |
|---|---|---|---|---|
| Caffeine metabolism | 0 | 0.15 | 12 | 1 |
| Purine metabolism | 0.01 | 0.62 | 68 | 1 |
| Tyrosine metabolism | 0.03 | 0.44 | 42 | 1 |
| Aminoacyl-tRNA biosynthesis | 0 | 0.22 | 64 | 2 |
| Vitamin B6 metabolism | 0 | 0.12 | 9 | 1 |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 0.5 | 0.05 | 4 | 1 |
| Phenylalanine metabolism | 0.41 | 0.12 | 9 | 1 |
| Linoleic acid metabolism | 1.00 | 0.06 | 5 | 1 |
| Biosynthesis of unsaturated fatty acids | 0 | 0.41 | 42 | 1 |
| Histidine metabolism | 0.27 | 0.17 | 14 | 1 |
| Nitrogen metabolism | 0 | 0.11 | 9 | 1 |
| Glycolysis or gluconeogenesis | 0.03 | 0.30 | 26 | 1 |
| Pyruvate metabolism | 0.06 | 0.26 | 22 | 1 |
| Propanoate metabolism | 0 | 0.24 | 20 | 1 |
Impact = pathway impact value calculated from pathway topology analysis; TC = total number of compounds in the pathway; Hit = matched number from the uploaded metabolite data.